Together with the decreased levels of BACE1 and amyloid-β40 in this subtype compared to controls (Table 1), suggesting decreased amyloid metabolism, these genetic factors suggests that impaired clearance mechanisms contribute to AD pathogenesis in subtype 4. This evidence concerns the gene BACE1 and Alzheimer disease.